Загрузка...
Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics
OBJECTIVES: With the wide range of biological disease-modifying anti-rheumatic drugs (bDMARDs) available for treating rheumatoid arthritis (RA), and limited evidence to guide the choice for individual patients, we wished to evaluate whether patient characteristics influence the choice of bDMARD in c...
Сохранить в:
| Опубликовано в: : | Ann Rheum Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5909744/ https://ncbi.nlm.nih.gov/pubmed/29237621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2017-212395 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|